Login / Signup

Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial.

Fabiola CarraraPiero RuggenentiAnnalisa PernaIlian Petrov IlievFlavio GaspariSilvia FerrariNadia StucchiAntonio Carlo BossiRoberto TrevisanGuiseppe RemuzziAneliya Parvanova
Published in: Acta diabetologica (2021)
DEMAND, NCT00157586, September 12, 2005.
Keyphrases
  • phase iii
  • clinical trial
  • study protocol
  • phase ii
  • open label
  • diabetic nephropathy
  • randomized controlled trial
  • high glucose